Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Colonic Disease

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43851   clinical trials with a EudraCT protocol, of which   7283   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    152 result(s) found for: Colonic Disease. Displaying page 1 of 8.
    1  2  3  4  5  6  7  8  Next»
    EudraCT Number: 2010-019805-41 Sponsor Protocol Number: AOBS-FOBERL-COBIOMAR Start Date*: 2010-07-02
    Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
    Full Title: Pharmacogenomics in optimizing the chemotherapy in the treatment of colorectal carcinoma
    Medical condition: COLORECTAL NEOPLASTIC DISEASE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009973 LLT
    9.1 10009974 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001927-36 Sponsor Protocol Number: 14/2007/U/Sper Start Date*: 2007-04-23
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Early ultrasonography role by Contrast enhanced ultrasonography ( CEUS) evaluating therapy effectiveness in patients with hepatic metastasis of colorectal cancer treated with antiangiogenetic drug.
    Medical condition: methastatic colorectal cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061045 Colon neoplasm LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000267-29 Sponsor Protocol Number: 0059718/05GENII6A Start Date*: 2006-01-01
    Sponsor Name:Centro sociale oncologico
    Full Title: Adjuvant chemotherapy in stage III colon carcinoma in patients age or 70 years. Feasibility of CAPOX scheme oxaliplatin 70 mg/mq days 1-8 and capecitabine 1000 mg/mq X 2 die days 1-14 every 21 da...
    Medical condition: Colon carcinoma
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061045 PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-023643-15 Sponsor Protocol Number: BUSCOPAN_PDR1 Start Date*: 2011-01-18
    Sponsor Name:Deventer Hospital
    Full Title: The influence of hyoscine N-butylbromide on colonoscopic polyp detection ratio
    Medical condition: It is investigated whether the administration of Buscopan will improve the detection, removal and harvesting of colonic polyps during colonoscopy.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10010007 Colonoscopy LLT
    12.1 10010003 Colonic polyp LLT
    12.1 10010036 Colorectal carcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-001437-14 Sponsor Protocol Number: IRFMN-CRC-7813 Start Date*: 2019-09-11
    Sponsor Name:Associazione Chirurghi Ospedalieri Italiani
    Full Title: Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcom...
    Medical condition: patients with colorectal carcinoma at high risk peritoneal carcinomatosis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10061045 Colon neoplasm PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-014556-29 Sponsor Protocol Number: TRIP Start Date*: 2010-03-14
    Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST
    Full Title: PHASE II TRIAL OF FOLFOXIRI PLUS PANITUMUMAB AS FIRST-LINE TREATMENT FOR KRAS AND BRAF WILD-TYPE METASTATIC COLORECTAL CANCER
    Medical condition: Metastatic colorectal carcinoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009973 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-006254-26 Sponsor Protocol Number: COMETS Start Date*: 2009-03-25
    Sponsor Name:GISCAD
    Full Title: Open-label randomized, parallel group, phase III, multicenter trial comparing two different sequences of therapy (irinotecan/cetuximab followed by fluorouracil/leucovorin with oxaliplat...
    Medical condition: Patients with histologically confirmed metastatic colorectal cancer progressed after a first line treatment containing FOLFIRI and BEV.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061045 Colon neoplasm LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000354-31 Sponsor Protocol Number: 69529029 Start Date*: 2007-03-30
    Sponsor Name:GISCAD
    Full Title: A randomized trial investigating the role of FOLFOX-4 regimen duration (3 versus 6 months) and bevacizumab as adjuvant therapy for patients with stage II/III colon cancer
    Medical condition: treatment of metastatic colorectal cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061045 Colon neoplasm LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002679-25 Sponsor Protocol Number: S60420 Start Date*: 2017-09-12
    Sponsor Name:KU Leuven
    Full Title: Characterization of colonic motility patterns in different functional bowel disorders compared to health and their role in moving content
    Medical condition: Functional bowel disorders; irritable bowel syndrome (constipation, diarrhea and mixed), chronic constipation, and chronic diarrhea.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002363-26 Sponsor Protocol Number: NeoCol Start Date*: 2013-07-23
    Sponsor Name:Vejle Hospital
    Full Title: Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer
    Medical condition: Colon cancer
    Disease: Version SOC Term Classification Code Term Level
    21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009951 Colon cancer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing) SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001007-11 Sponsor Protocol Number: FOIB-ML20004 Start Date*: 2006-10-31
    Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST
    Full Title: OPEN-LABEL, MULTICENTER, PHASE II STUDY OF FIRST- LINE BI-WEEKLY IRINOTECAN, OXALIPLATIN AND INFUSIONAL 5FU/LV (FOLFOXIRI) IN COMBINATION WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CAN...
    Medical condition: IN PATIENTS WITH METASTATIC COLORECTAL CANCER.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009945 Colonic neoplasms malignant HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-006046-12 Sponsor Protocol Number: 011121 Start Date*: 2022-07-06
    Sponsor Name:Rigshospitalet
    Full Title: Efficacy of immunotherapy in patients with MMR-deficient localized colon cancer scheduled for curative surgery - A prospective, phase II study
    Medical condition: Patients with early stage (stage I-III) dMMR colon cancer
    Disease: Version SOC Term Classification Code Term Level
    21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009951 Colon cancer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024380-41 Sponsor Protocol Number: SPON868-10 Start Date*: 2011-08-25
    Sponsor Name:Cardiff University
    Full Title: A pilot study to assess the effect of regulatory T-cell depletion on 5T4-containing MVA(TroVax®)vaccination in patients with inoperable metastatic colorectal cancer
    Medical condition: Inoperable metastatic colorectal cancer
    Disease: Version SOC Term Classification Code Term Level
    13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009951 Colon cancer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-002494-48 Sponsor Protocol Number: version 1.0, 02 May 2006 Start Date*: 2006-09-27
    Sponsor Name:University College London / University College London Hospitals NHS Foundation Trust
    Full Title: Sildenafil in Crohn’s disease: an open label pilot study of Sildenafil in 15 patients with active colonic Crohn’s disease
    Medical condition: Active colonic Crohn's disease
    Disease: Version SOC Term Classification Code Term Level
    8.1 10011402 Crohn's disease (colon) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-004228-22 Sponsor Protocol Number: IBS/DIV 08 Start Date*: 2008-12-15
    Sponsor Name:SOFAR SPA
    Full Title: Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study
    Medical condition: Irritable bowel Syndrome Diverticular disease of the colon
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009993 LLT
    9.1 10023004 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005657-24 Sponsor Protocol Number: PERMAD01 Start Date*: 2014-12-19
    Sponsor Name:Universitätsklinikum Ulm
    Full Title: Personalized marker-driven early switch to aflibercept in patients with metastatic colorectal cancer. A run in marker determination phase followed by a marker-driven randomized part - a multicenter...
    Medical condition: colorectal cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009944 Colon cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-002623-15 Sponsor Protocol Number: GS11/9681 Start Date*: 2013-09-30
    Sponsor Name:University of Leeds
    Full Title: GLiSten: Next generation intraoperative lymph node staging for stratified colon cancer surgery- Development Phase
    Medical condition: Colon cancer
    Disease: Version SOC Term Classification Code Term Level
    17.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009944 Colon cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Prematurely Ended) GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-005200-96 Sponsor Protocol Number: ZUH-LAP-HEMI-TQL Start Date*: 2018-03-09
    Sponsor Name:Associate Professor, Consultant Jens Børglum
    Full Title: Improving perioperative pain management for laparoscopic surgery due to colon cancer using the ultrasound-guided Transmuscular Quadratus Lumborum block. A double blind, randomized, placebo controll...
    Medical condition: Postoperative pain following laparoscopic hemicolectomy or sigmoidectomy due to coloncancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10009951 Colon cancer NOS LLT
    20.0 100000004865 10078463 Laparoscopic partial colectomy LLT
    20.1 100000004863 10054711 Postoperative pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006561-89 Sponsor Protocol Number: CA196-004 Start Date*: 2009-06-30
    Sponsor Name:Bristol Myers Squibb International Corporation
    Full Title: A Randomized, Double-Blind, Phase II Trial of CT-322 (BMS-844203) plus Irinotecan, 5-FU and Leucovorin (FOLFIRI) versus Bevacizumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal C...
    Medical condition: Second-Line Treatment for Metastatic Colorectal Cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052362 Metastatic colorectal cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-000629-32 Sponsor Protocol Number: MO17092 Start Date*: 2006-12-21
    Sponsor Name:University of Oxford
    Full Title: Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer
    Medical condition: adjuvant treatment of colorectal cancer
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed) AT (Completed) CZ (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Apr 20 03:33:59 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA